Statera Biopharma, Inc. — Form D

Statera Biopharma, Inc. of Fort Collins, CO, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-23. The offering totals $1.1M, of which $1.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (56)

Showing 25 of 56 people.

NameRoleLocation
James J AntalDirectorBuffalo, NY
Anna Neil EvdokimovaDirectorBuffalo, NY
Konstantin Neil GorshkovDirectorBuffalo, NY
Andrei J GudkovDirectorBuffalo, NY
Natalia Neil KhudykDirectorBuffalo, NY
Yakov J KoganDirectorBuffalo, NY
Yulia Neil LebedinaDirectorBuffalo, NY
Tatiana Neil LevinaDirectorBuffalo, NY
Richard S McGowanDirectorWESTMINSTER, MA
Ivan Neil PersiyanovDirectorBuffalo, NY
Anthony J PrincipiDirectorBuffalo, NY
Randy S SaluckDirectorBuffalo, NY
Natalia Neil SaraevaDirectorBuffalo, NY
Andrei J GudkovExecutive OfficerBuffalo, NY
Yakov J KoganExecutive OfficerBuffalo, NY
C Neil LyonsExecutive OfficerBuffalo, NY
Langdon Neil MillerExecutive OfficerBuffalo, NY
Yakov KoganDirectorSalt Lake City, UT
Yakov KoganExecutive OfficerSalt Lake City, UT
Daniel PerezDirectorSan Francisco, CA
Robert Kevin BuckheitExecutive OfficerFort Collins, CO
Blake Kevin HawleyDirectorFort Collins, CO
Satish Kevin ChandrenDirectorFort Collins, CO
Uday Kevin SaxenaDirectorFort Collins, CO
John Kevin KallassyDirectorFort Collins, CO

Other filings by this issuer (6)

FiledFormOfferingSold
2022-11-07D$765K$577K
2020-06-04D$1.6M$1.6M
2015-07-16D$25.0M$25.0M
2014-07-03D$3.5M$3.5M
2010-03-05D$5.0M$5.0M
2009-04-03D$3.7M$3.7M

More